Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria (Q44939356)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria |
scientific article |
Statements
1 reference
Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria (English)
1 reference
1 reference
Michiel E H Hemels
1 reference
Evelyn Walter
1 reference
Thomas R Einarson
1 reference
1 June 2004
1 reference
1 reference
20
1 reference
6
1 reference
869-878
1 reference
Identifiers
1 reference
1 reference